India’s Manipal AcuNova acquires German firm Ecron
Clinical research firm Manipal AcuNova Ltd recently announced it has completed the acquisition of ECRON GmbH, Europe.
Clinical research firm Manipal AcuNova Ltd recently announced it has completed the acquisition of ECRON GmbH, Europe.
The LORENZ Life Sciences Group announced recently that Orchid Chemicals & Pharmaceuticals, located in Chennai, India has chosen docuBridge as its eCTD Publishing and Management solution.
Biotechnology company Shreya Lifesciences has entered into an in-licensing agreement with US-based Generex Biotechnology Corp to market Oral-lyn, the country
A report from research firm KPMG predicts that the domestic pharmaceutical industry is projected to grow by 16 per cent annually for the next five years, three percentage points more than the current growth rate.
Private Equity (PE) investments in the domestic healthcare and pharma industry have touched around $400 million during the first nine months of the year. This trend is set to accelerate as companies go for overseas acquisitions, hive off their R&D units, and Foreign Currency Convertible Bonds (FCCB) lose their sheen.
The Mumbai based Electrolab, manufacturer of dissolution tester for pharma industry in the country, will launch an online connectivity software next month.
Indian drug maker Wockhardt recently acquired US-based speciality drugs company Morton Grove Pharmaceuticals, which has annual sales of $52 million.
Thermo Fisher Scientific Inc. , the world leader in serving science, today announced it has broken ground on a new USD 17 million facility in Ahmadabad, India, to support growing demand for biopharma services in that country.
Pharmaceuticals major Ranbaxy Laboratories plans to make China its major sourcing hub for active pharmaceutical ingredient (API).
Pfizer Inc and Sermo, the largest online physician community in the US, have announced a strategic collaboration designed to redefine the way physicians in the U.S. and the healthcare industry work together to improve patient care.
Quest Diagnostics announced recently that it has joined the National ePrescribing Patient Safety Initiative (NePSI), and will offer physicians access to its Care360 Physician Portal and results capabilities.
As pharma biggies like Ranbaxy and Dr Reddy